The Frontier of Biosensors: The Polymerase Chain Reaction‐Free Approach for Point‐of‐Care Devices

The nucleic acids (NA) analysis is spread out by the invention of polymerase chain reaction (PCR). Even though the method has proven to be a disruptively innovation in the medical field, by creating a new of sector of molecular diagnostics, it however remains the prerogative of analysis of laboratories, due to its complexity and cost. To further make progresses in this sector, the development of point‐of‐care (POC) genetic testing technologies is crucial by offering the advantages to be fast, sensitive and specific, low cost, and, above all, able to be used onsite by nonspecialized people. In this context, the PCR‐free approaches are very relevant since they do not need amplification processes and, therefore, they simplify significantly the experimental set up aimed to detect the NA. In this perspective, an overview of most innovative approaches for genetic point care technologies rapid test is presented and discussed particularly appealing to be integrated in portable and easy‐to‐use POC devices.

Authors

Institutions

Publication Details

Journal
ChemistryEurope
Published
2025-06-30
DOI
https://doi.org/10.1002/ceur.202400117
Primary Topic
Biosensors and Analytical Detection
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Frontier of Biosensors: The Polymerase Chain Reaction‐Free Approach for Point‐of‐Care Devices

Sabrina Conoci
ChemistryEurope
Biosensors and Analytical Detection
article

The Frontier of Biosensors: The Polymerase Chain Reaction‐Free Approach for Point‐of‐Care Devices

Sabrina Conoci
article en

Abstract

The nucleic acids (NA) analysis is spread out by the invention of polymerase chain reaction (PCR). Even though the method has proven to be a disruptively innovation in the medical field, by creating a new of sector of molecular diagnostics, it however remains the prerogative of analysis of laboratories, due to its complexity and cost. To further make progresses in this sector, the development of point‐of‐care (POC) genetic testing technologies is crucial by offering the advantages to be fast, sensitive and specific, low cost, and, above all, able to be used onsite by nonspecialized people. In this context, the PCR‐free approaches are very relevant since they do not need amplification processes and, therefore, they simplify significantly the experimental set up aimed to detect the NA. In this perspective, an overview of most innovative approaches for genetic point care technologies rapid test is presented and discussed particularly appealing to be integrated in portable and easy‐to‐use POC devices.

ChemistryEuropeVol. 3(4)
University of Messina (IT), University of Bologna (IT)
European Commission, HORIZON EUROPE Framework Programme
Industry, innovation and infrastructure
Openalex Percentile: Top 86%
Biosensors and Analytical Detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Frontier of Biosensors: The Polymerase Chain Reaction‐Free Approach for Point‐of‐Care Devices — Sabrina Conoci · ChemistryEurope (2025) | TGRS Research Map | TGRS